Published in Acta Neurochir Suppl on January 01, 2003
Reflux-free cannula for convection-enhanced high-speed delivery of therapeutic agents. J Neurosurg (2005) 2.07
Immunotoxins for targeted cancer therapy. AAPS J (2006) 1.86
Image-guided convection-enhanced delivery platform in the treatment of neurological diseases. Neurotherapeutics (2008) 1.79
Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma. Neuro Oncol (2010) 1.78
Intracerebral infusion of an EGFR-targeted toxin in recurrent malignant brain tumors. Neuro Oncol (2008) 1.59
Detection of infusate leakage in the brain using real-time imaging of convection-enhanced delivery. J Neurosurg (2008) 1.40
Clinical utility of a patient-specific algorithm for simulating intracerebral drug infusions. Neuro Oncol (2007) 1.39
Striatal volume differences between non-human and human primates. J Neurosci Methods (2008) 1.33
Convection-enhanced delivery of Ls-TPT enables an effective, continuous, low-dose chemotherapy against malignant glioma xenograft model. Neuro Oncol (2006) 1.29
Optimized cannula design and placement for convection-enhanced delivery in rat striatum. J Neurosci Methods (2009) 1.25
Optimal region of the putamen for image-guided convection-enhanced delivery of therapeutics in human and non-human primates. Neuroimage (2009) 1.24
Novel drug delivery strategies in neuro-oncology. Neurotherapeutics (2009) 1.21
Convection-enhanced delivery of nanoliposomal CPT-11 (irinotecan) and PEGylated liposomal doxorubicin (Doxil) in rodent intracranial brain tumor xenografts. Neuro Oncol (2007) 1.21
Safety of real-time convection-enhanced delivery of liposomes to primate brain: a long-term retrospective. Exp Neurol (2007) 1.14
Gene therapy and targeted toxins for glioma. Curr Gene Ther (2005) 1.02
Toxin-based therapeutic approaches. Toxins (Basel) (2010) 1.00
Gene therapy and targeted toxins for glioma. Curr Gene Ther (2011) 0.97
Targeted toxins in brain tumor therapy. Toxins (Basel) (2010) 0.91
Generating differentially targeted amyloid-beta specific intrabodies as a passive vaccination strategy for Alzheimer's disease. Mol Ther (2009) 0.90
Calcium-activated potassium channels mediated blood-brain tumor barrier opening in a rat metastatic brain tumor model. Mol Cancer (2007) 0.89
Gene therapy trials for the treatment of high-grade gliomas. Gene Ther Mol Biol (2007) 0.88
Ultrasound-enhanced drug transport and distribution in the brain. AAPS PharmSciTech (2010) 0.86
Significance of interleukin-13 receptor alpha 2-targeted glioblastoma therapy. Neuro Oncol (2014) 0.84
Convection-enhanced delivery improves distribution and efficacy of tumor-selective retroviral replicating vectors in a rodent brain tumor model. Cancer Gene Ther (2013) 0.84
Drug conjugates such as Antibody Drug Conjugates (ADCs), immunotoxins and immunoliposomes challenge daily clinical practice. Int J Mol Sci (2012) 0.83
Therapeutic strategies to improve drug delivery across the blood-brain barrier. Neurosurg Focus (2015) 0.83
Current immunotherapeutic strategies for central nervous system tumors. Surg Oncol Clin N Am (2007) 0.82
Neurological grading, survival, MR imaging, and histological evaluation in the rat brainstem glioma model. Childs Nerv Syst (2008) 0.81
Convection-enhanced delivery for targeted delivery of antiglioma agents: the translational experience. J Drug Deliv (2013) 0.80
The potential of theragnostic ¹²⁴I-8H9 convection-enhanced delivery in diffuse intrinsic pontine glioma. Neuro Oncol (2014) 0.79
Highly compacted pH-responsive DNA nanoparticles mediate transgene silencing in experimental glioma. J Mater Chem B Mater Biol Med (2014) 0.77
Novel therapeutic delivery approaches in development for pediatric gliomas. CNS Oncol (2013) 0.77
IL-13 receptor α2 is a negative prognostic factor in human lung cancer and stimulates lung cancer growth in mice. Oncotarget (2015) 0.76
Clinical development of experimental therapies for malignant glioma. Sultan Qaboos Univ Med J (2011) 0.75
Convection-enhanced Delivery of Therapeutics for Malignant Gliomas. Neurol Med Chir (Tokyo) (2016) 0.75